Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

134.43
Delayed Data
As of 3:59pm ET
 +3.00 / +2.28%
Today’s Change
71.75
Today|||52-Week Range
153.15
+34.07%
Year-to-Date
Tanger Factory Outlet Centers, Gilead Sciences, Qorvo: 'Mad Money' Lightning Round
May 19 / TheStreet.com - Paid Partner Content
Concert Pharma Falls After Clinical Hold on Hair Loss Drug
May 18 / Zacks.com - Paid Partner Content
Company News for May 19, 2017
May 19 / Zacks.com - Paid Partner Content
Biotech Movers: Fast Track Designation Sends Sage Shares Higher
May 18 / TheStreet.com - Paid Partner Content
Walgreens Boots Alliance, Becton Dickinson, General Mills: 'Mad Money' Lightning Roun...
May 18 / TheStreet.com - Paid Partner Content
Incyte Shares Vault After 'IDO' Cancer Immunotherapy Combo Data Revealed
May 17 / TheStreet.com - Paid Partner Content
Going for the Growth: Cramer's 'Mad Money' Recap (Thursday 5/18/17)
May 18 / TheStreet.com - Paid Partner Content
Aduro Biotech, Merck Team on Cancer Drug Trial
May 17 / TheStreet.com - Paid Partner Content
Incyte (INCY) Announces Positive Data on Enzyme Inhibitor
May 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close131.43
Today’s open131.20
Day’s range130.22 - 134.89
Volume2,031,461
Average volume (3 months)2,398,697
Market cap$26.9B
Dividend yield--
Data as of 3:59pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-235.32%
Earnings growth (next 5 years)+64.80%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book59.17

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+1.58+1.39%
VRTXVertex Pharmaceutica...+0.92+0.78%
ZTSZoetis Inc0.000.00%
BAXBaxter International...+0.44+0.77%
Data as of 4:01pm ET, 05/22/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.01
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts